Breakthroughs in advances in endocrine research and molecular endocrinology are revolutionizing the diagnosis and treatment of metabolic diseases. The discovery of novel hormone signaling pathways has deepened understanding of insulin resistance and beta-cell dysfunction. Molecular research has also identified genetic markers linked to endocrine disorders, paving the way for personalized medicine. Gene-editing technologies, including CRISPR, are being explored for their potential in correcting inherited hormonal deficiencies. Emerging therapies targeting hormonal receptors offer new treatment avenues for diabetes and obesity-related conditions. By combining molecular endocrinology with clinical applications, scientists are developing innovative strategies to improve endocrine health and metabolic stability.
F Buck Willis
Christian College of Medicine, Belize
Mahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab Emirates
Anil Harrison
Midwestern University, United States
Wan Rosli Wan Ishak
Universiti Sains Malaysia, MalaysiaMahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab Emirates
Sujith Rajan
NYU Long Island School of Medicine, United StatesWan Rosli Wan Ishak
Universiti Sains Malaysia, Malaysia
Madhu S Malo
Stapgen LLC, United States
Kaishi Yang
Albert Einstein College of Medicine, United States
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar, Karnataka Institute of Endocrinology and Research
Title : An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou, Southern Medical University
Title : Impact of Intermittent fasting on glycemic control in adults with Type 2 diabetes: A systematic review of randomized controlled trials
Shaheen Kaplan, Avalon University School of Medicine
Title : Metabolic health across generations: preventing and controlling diabetes in the modern era
Souravh Bais, Institute of Pharmaceitical Sciences, SAGE University Indore
Title : Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal, New Era Consultancy Services